Understanding the SLC6A3 gene, its polymorphisms, and its mechanisms’ role in MDD etiology might contribute to the establishment of new, more modern forms of early diagnosis and increase patients’ quality of life. This evidence concerns the gene SLC6A3 and major depressive disorder.